Opexa Therapeutics

info@opexatherapeutics.com

2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005

News and Resources

2013 Releases

02/07/2022 - Opexa Therapeutics, Inc. Announces Pricing of Common Stock and Warrant Offering

02/07/2022 - Opexa Therapeutics to Present at the 15th Annual BIO CEO & Investor Conference

02/05/2022 - Merck Serono and Opexa Therapeutics Enter into Option and License Agreement for Development of Tcelna™ (imilecleucel-T) for Treatment of Multiple Sclerosis

01/23/2013 - Opexa Therapeutics Closes Private Note Offering

01/15/2013 - Opexa Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement